Anthony S. Tavill, M.D., F.A.C.P., F.R.C.P., F.A.C.G. (1936‐2016)
Arthur J. McCullough – 27 October 2016
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease‐hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
Delia D'Avola, Ismail Labgaa, Augusto Villanueva – 27 October 2016
The transition from inflammation to cancer in the liver
Augusto Villanueva, Tom Luedde – 27 October 2016
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease‐hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
Delia D'Avola, Ismail Labgaa, Augusto Villanueva – 27 October 2016
Defining disparities in liver transplantation: The devil is in the details
David S. Goldberg – 27 October 2016
Cost‐effectiveness of augmenting current perinatal hepatitis B prevention program with maternal antiviral therapy
Gang Qin, Xun Zhuang – 27 October 2016
New organ allocation policy in liver transplantation in the United States
David A. Goldberg, Richard Gilroy, Michael Charlton – 27 October 2016
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease‐hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
Delia D'Avola, Ismail Labgaa, Augusto Villanueva – 27 October 2016
New pharmacological approaches to a functional cure of hepatitis B
Wai‐Kay Seto, Man‐Fung Yuen – 27 October 2016
Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma
Stefano Bellentani, Gianluca Svegliati Baroni, Fabio Piscaglia, Claudio Tiribelli – 27 October 2016